PDA

View Full Version : March 2008


  1. [Marked effect of combination chemotherapy with tegafur-gimeracil-oteracil potassium
  2. [A case report of pseudomyxoma peritonei demonstrating complete response after intens
  3. [Concurrent chemoradiotherapy for squamous cell carcinoma of the anal canal-report of
  4. [A case of advanced rectal cancer responding to radiation therapy and chemotherapy wi
  5. [A Long Survival Case of Advanced Colon Cancer with Lung Metastasis and Cancerous Ple
  6. [A Successfully Resected Case of Colorectal Cancer with Multiple Liver Metastases Tre
  7. [A Case of Complete Response Treated by Gastrectomy with Lymphadenectomy and Combined
  8. [A Case of Advanced Gastric Cancer Responding to Neoadjuvant S-1/CDDP Therapy.]
  9. [Squamous cell carcinoma of the lower lip, completely responding to concurrent chemor
  10. [Two cases of severe myelosuppression from amrubicin in previously-treated small cell
  11. [A patient with small cell lung cancer who developed a drug eruption due to concomita
  12. [Combination of Carboplatin and Gemcitabine Is a Safe and Feasible Regimen in Adjuvan
  13. [A Case of Multidrug-Resistant Squamous Cell Lung Carcinoma Responding to S-1 Plus CP
  14. [A case of triple negative recurrent breast cancer successfully treated with capecita
  15. [An Advanced Metastatic Breast Cancer Patient Successfully Treated with Combination T
  16. [Side Effects of FEC100.]
  17. [Retrospective Analysis of FOLFOX4 Neurotoxicity for Recovery from Advanced Colorecta
  18. [Therapeutic experience of s-1 plus other drug combination therapy for synchronia mul
  19. [Present status and prospects for chemotherapy for advanced or recurrent gastric canc
  20. [omega-3 Fatty Acid-Containing Diet (Racol (R)) Reduces Toxicity of Chemoradiation Th
  21. [Significance of pyrimidine nucleoside phosphorylase and dihydropyrimidine dehydrogen
  22. [Adjuvant chemotherapy with s-1 for head and neck carcinoma.]
  23. [International Standards of Cancer Treatment-Looking Back on Patient Activities that
  24. [Cancer care in the new era-special emphasis on physician?s mind-set anticipated in r
  25. [Foster Plans for Cancer Specialists Selected by MEXT in Japan.]
  26. [National cancer act and council for national cancer strategy.]
  27. [Ion beam treatment-a new medical treatment system.]
  28. Anthracycline associated cardiotoxicity in survivors of childhood cancer.
  29. Telomere length is shorter in healthy offspring of subjects with coronary artery dise
  30. Medical treatment of Marfan syndrome: a time for change.
  31. Prevalence of cognitive impairment without dementia in the United States.
  32. Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced
  33. Universal Surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliate
  34. Systematic Review: The Effects of Growth Hormone on Athletic Performance.
  35. Active tails enhance arboreal acrobatics in geckos.
  36. HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that rev
  37. Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dop
  38. Repetition suppression of ventromedial prefrontal activity during judgments of self a
  39. Close correspondence between quantitative- and molecular-genetic divergence times for
  40. Activation of Trk neurotrophin receptors by glucocorticoids provides a neuroprotectiv
  41. Linking Notch signaling to ischemic stroke.
  42. Myosin V and Kinesin act as tethers to enhance each others’ processivity.
  43. Ischemic preconditioning blocks BAD translocation, Bcl-xL cleavage, and large channel
  44. Monolayer purification: A rapid method for isolating protein complexes for single-par
  45. Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-
  46. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the develo
  47. A Gene Expression Network Model of Type 2 Diabetes Links Cell Cycle Regulation in Isl
  48. De novo search for non-coding RNA genes in the AT-rich genome of Dictyostelium discoi
  49. Uniparental disomy of chromosome 1 causing concurrent charcot-marie-tooth and Gaucher
  50. Human herpesvirus-6 variant a encephalomyelitis.
  51. Weir Mitchell’s 1859 demonstration of ”a peculiar contraction” produced by a percussi
  52. Diffusion tensor imaging of acute mild traumatic brain injury in adolescents.
  53. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
  54. abcy@hotmail.com
  55. The Influence of Collaboration on Program Outcomes: The Colorado Nurse–Family Partner
  56. Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated
  57. Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results fro
  58. Toll-like Receptor 4 Mediates an Antitumor Host Response Induced by Salmonella choler
  59. Sensitivity of squamous cell carcinoma lymph node metastases to herpes oncolytic ther
  60. Novel Delivery of SN38 Markedly Inhibits Tumor Growth in Xenografts, Including a Camp
  61. Ataxia Telangiectasia Mutated and p21CIP1 Modulate Cell Survival of Drug-Induced Sene
  62. Inhibition of the Tumor Necrosis Factor-{alpha} Pathway Is Radioprotective for the Lu
  63. Radiation Enhances Adenoviral Gene Therapy in Pancreatic Cancer via Activation of Cyt
  64. Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenstrom’s
  65. Vitamin E Succinate Induces Ceramide-Mediated Apoptosis in Head and Neck Squamous Cel
  66. Synergistic Antipancreatic Tumor Effect by Simultaneously Targeting Hypoxic Cancer Ce
  67. Cytotoxicity and Proteomics Analyses of OSU03013 in Lung Cancer.
  68. Antimyeloma effects of a sesquiterpene lactone parthenolide.
  69. Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multi
  70. Correlation of CDA, ERCC1, and XPD Polymorphisms with Response and Survival in Gemcit
  71. Irinotecan pharmacogenetics: influence of pharmacodynamic genes.
  72. Improving the quality of abstract reporting for phase I cancer trials.
  73. Prognostic factors in renal cell carcinoma: association of preoperative sodium concen
  74. Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based The
  75. Topoisomerase II{alpha} Expression as an Independent Prognostic Factor in Hodgkin’s L
  76. Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by prote
  77. IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the Bladder.
  78. Endothelial differentiation of hematopoietic stem and progenitor cells from patients
  79. Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results fro
  80. Toll-like Receptor 4 Mediates an Antitumor Host Response Induced by Salmonella choler
  81. Sensitivity of squamous cell carcinoma lymph node metastases to herpes oncolytic ther
  82. Novel Delivery of SN38 Markedly Inhibits Tumor Growth in Xenografts, Including a Camp
  83. Ataxia Telangiectasia Mutated and p21CIP1 Modulate Cell Survival of Drug-Induced Sene
  84. Inhibition of the Tumor Necrosis Factor-{alpha} Pathway Is Radioprotective for the Lu
  85. Radiation Enhances Adenoviral Gene Therapy in Pancreatic Cancer via Activation of Cyt
  86. Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenstrom’s
  87. Vitamin E Succinate Induces Ceramide-Mediated Apoptosis in Head and Neck Squamous Cel
  88. Synergistic Antipancreatic Tumor Effect by Simultaneously Targeting Hypoxic Cancer Ce
  89. Cytotoxicity and Proteomics Analyses of OSU03013 in Lung Cancer.
  90. Antimyeloma effects of a sesquiterpene lactone parthenolide.
  91. Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multi
  92. Correlation of CDA, ERCC1, and XPD Polymorphisms with Response and Survival in Gemcit
  93. Irinotecan pharmacogenetics: influence of pharmacodynamic genes.
  94. Improving the quality of abstract reporting for phase I cancer trials.
  95. Prognostic factors in renal cell carcinoma: association of preoperative sodium concen
  96. Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based The
  97. Overall and Relapse-Free Survival in Oropharyngeal and Hypopharyngeal Squamous Cell C
  98. A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Prim
  99. Identification of prognostic biomarkers for prostate cancer.